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A disturbed, inconsistent walking pattern is a common feature of patients with
Parkinson’s disease (PwPD). Such extreme variability in both temporal and spatial
parameters of gait has been associatedwith unstable walking and an elevated prevalence
of falls. However, despite their ability to discretise healthy from pathological function,
normative variability values for key gait parameters are still missing. Furthermore, an
understanding of each parameter’s response to pathology, as well as the inter-parameter
relationships, has received little attention. The aim of this systematic literature review
and meta-analysis was therefore to define threshold levels for pathological gait variability
as well as to investigate whether all gait parameters are equally perturbed in PwPD.
Based on a broader systematic literature search that included 13′195 titles, 34 studies
addressed Parkinson’s disease, presenting 800 PwPD and 854 healthy subjects. Eight
gait parameters were compared, of which six showed increased levels of variability during
walking in PwPD. The most commonly reported parameter, coefficient of variation of
stride time, revealed an upper threshold of 2.4% to discriminate the two groups. Variability
of step width, however, was consistently lower in PwPD compared to healthy subjects,
and therefore suggests an explicit sensory motor system control mechanism to prioritize
balance during walking. The results provide a clear functional threshold for monitoring
treatment efficacy in patients with Parkinson’s disease. More importantly, however,
quantification of specific functional deficits could well provide a basis for locating the
source and extent of the neurological damage, and therefore aid clinical decision-making
for individualizing therapies.
Keywords: gait variability, walking balance, dynamic stability, systematic review, meta-analysis, quality of
movement, rhythmicity
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INTRODUCTION
Disturbance of normal walking patterns, caused by symptoms
such as akinesia and loss of postural reflexes, is a well-
acknowledged problem in patients with Parkinson’s disease
(PwPD) (Hausdorff, 2009). With the progression of the disease,
balance, gait, and mobility are increasingly impaired, causing a
loss of independence, and consequently a reduction in the quality
of life (Damiano et al., 1999; Ellis et al., 2011). This loss of
function, mobility, and independence is associated with further
complications such as cognitive impairments, sleep disorders
(Imbach et al., 2012), depression, cardiovascular diseases (Ton
et al., 2010, 2012), and injuries and fatalities (Balash et al., 2005).
Despite established pharmaceutical and surgical therapies for
treating motor symptoms in PwPD, the disease poses immense
challenges for clinicians to identify the disease onset at an
early time point, provide a long-term objective evaluation and
monitoring of therapies, but also to quantify differences between
therapies.
Although, a number of recognized biomarkers for the clinical
identification and evaluation of Parkinson’s disease (PD) exist
(Andersen et al., 2016; Salat et al., 2016), objective methods to
measure human movement have become increasing available,
and now provide the potential to complement clinical decision-
making (Lord et al., 2011a, 2013). In an attempt to translate
parameters derived from kinematics into an understanding
of movement quality, several measures of both spatial and
temporal gait have been investigated: summary measures based
on the statistical mean (e.g., mean stride length; Faist et al.,
2001; Ferrarin et al., 2005; Hausdorff, 2009), measures to
quantify variability during walking based on the standard
deviation (e.g., coefficient of variation of stride length; Blin
et al., 1990, 1991; Hausdorff et al., 1998; Baltadjieva et al.,
2006; Roemmich et al., 2012), measures to quantify bilateral
symmetry of walking (e.g., phase coordination index; Plotnik
et al., 2007; Plotnik and Hausdorff, 2008; Johnsen et al., 2009;
Fasano et al., 2011), and non-linear algorithms that evaluate
the structure of gait signals in relation to their temporal
evolution (e.g., Lyapunov exponent; Dingwell and Cusumano,
2000; Bruijn et al., 2013; Roemmich et al., 2013). However,
since PD is known to disturb rhythmicity of walking (constancy
of step repetitions), mean measures for assessing degeneration
of this temporal parameter simply result in averaging out
any modifications and are therefore entirely insensitive. As
a result, only parameters that highlight non-constancy over
multiple repetitions can provide objective interpretation of
modifications that occur with degeneration due to PD. While
non-linear and bilateral symmetry measures of walking provide
promising candidates for evaluating such degeneration, due to
their simple implementation, parameters of gait variability have
so far received the most attention (Hamacher et al., 2011; Lord
et al., 2011a; Konig et al., 2014a). However, until now, thorough
evaluation of measures of variability for understanding the
quality of movement remains missing, and in particular, which
threshold levels of gait variability can be considered physiological
vs. pathological.
Generally, motor variability increases with aging and
pathology while functional performance decreases. As a
consequence, variability has been assumed to be detrimental
for task performance (Hamacher et al., 2011; König et al.,
2016). Traditionally, motor variability was thought to be the
result of noisy signaling processes within the human sensory
motor system (HSMS). However, recently it has been shown
that motor variability can be adapted depending on the motor
task requirements, and can also play an important role for
successful motor learning (Roerdink et al., 2006; Dingwell and
Kang, 2007; Wilson et al., 2008; Russell and Haworth, 2014;
Wu et al., 2014; Pekny et al., 2015). As a result, it appears that
motor variability is an integral aspect of human movement
as well as a prerequisite for effective task performance. It has
been argued that excessively high levels of variability render
task performance unstable, whereas extremely low levels result
in rigid motor performance, hampering the subject’s ability to
respond to changing environmental conditions. As a result, it
seems plausible that an optimal level of variability for successful
task performance exists (Todorov and Jordan, 2002; Stergiou
et al., 2006). Indeed, in a large systematic review of the literature,
it has recently been revealed that an optimalwindow of variability
during walking and balancing exists, and which was somewhat
consistent across a variety of neuromotor pathologies including
stroke, brain injury, and disorders of the basal ganglia etc (König
et al., 2016). However, while a consistent window of optimal
levels of variability of stride time was presented, it remains
unknown whether all parameters of variability respond in a
similar manner to degenerated motor control in extrapyramidal
diseases.
An efficient walking pattern is characterized by a plethora
of concepts such as rhythmicity, regularity, bilateral, and inter-
segment coordination, balance control during one-legged and
double limb support phases, and controlled forward progression
etc., as well as the maintenance of boundary constraints such
as sufficient toe clearance to avoid obstacles (Lord et al., 2013).
However, such complex concepts to represent gait quality cannot
be readily captured in any single parameter, and also not
described in terms of quantity (less may not necessarily be
better). An additional difficulty in quantifying the degeneration
of gait quality due to pathology is that gait is controlled
by the coordinated action of various central and peripheral
neural circuits (Dietz, 1992, 2002, 2003; Arshavsky et al., 1997;
Rosano et al., 2008). As a result, the primary understanding
of many neural control mechanisms until now has come from
clinical observations of various gait abnormalities (e.g., gait in
hypokinetic vs. hyperkinetic disorders) in patients with known
neuro-motor diseases, rather than an objective quantification of
parameter deviations. For example, an observation of reduced
step length in PwPD does not permit conclusions regarding the
quality of walking, nor is it indicative of the underlying neural
deficit. Importantly, these subjective observations generally lack
sensitivity for the early identification of subtle and/or emerging
pathologies.
In order to enable improved interpretation of gait metrics
in clinical settings for diagnosis and assessment of gait quality
and thus treatment effects in PwPD, the aim of this systematic
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literature review and meta-analysis was therefore to (1) establish
whether different gait parameters are indicative of pathological
disturbances of the HSMS in PwPD and (2) to define clear
threshold values for healthy and pathological gait variability.
METHODS
Literature Search and Selection
The data presented here comprises a follow-up analysis of a wider
systematic review that compared motor variability in patients
with various neurological diseases against the levels observed in
asymptomatic subjects (König et al., 2016). While it achieved
a new perspective on the effect of pathology on stride time
variability, providing for the first time a window of optimal
variability, it did not address the distinct effects of pathology on
different measures of gait. In this current study, we therefore
focus specifically on literature assessing measures to quantify
variability during walking based on the standard deviation in
PwPD.
The original systematic literature search was conducted with
the aim to comprehensively identify studies in which measures
of motor variability during walking and standing were collected
in both a cohort of healthy elderly and a cohort of patients with
a neurological pathology (König et al., 2016). There, a common
search string was entered into four different databases (Pubmed,
ISI Web of Knowledge, Embase and Ebsco). The search string
contained Boolean operators such that an AND-combination of
terms specified the task (e.g., walk∗), measure (e.g., variability),
and cohort (e.g., Parkin∗). Within these categories synonyms
as well as specifications of additional pathological cohorts were
combined using the OR operator. The search was limited to
original research articles published after the year 1980. Initially,
the search revealed 13′195 publications potentially relevant
for addressing the question of motor variability across neural
pathologies. In two steps, eligibility of studies was assessed using
the double-screening method (NK & NS) firstly on the titles
and abstracts, followed by examining the methods section of
each publication. Here, publications were selected according to
pre-defined inclusion and exclusion criteria, and disagreement
between reviewers was solved by consensus. Based on the 109
publications included in the original review, a further reduction
of titles was undertaken in order to focus on studies addressing
walking performance in PwPD, resulting in a total of 34 papers.
Meta-Analysis
The aim of the meta-analysis was two-fold: Firstly, to determine
threshold levels of gait variability that discriminates healthy
controls (HCs) from PwPD, and secondly to identify whether
all variability metrics are indeed elevated in PwPD. In order to
achieve this, means and standard deviations (SD) of the various
measures of gait variability for both asymptomatic and PwPD
cohorts were extracted. In cases where standard error of themean
or 95% confidence intervals (95%CI) were presented, these values
were translated into SD as recommended by Cochrane (Higgins,
2011). An effect size (ES) for each study was then determined
according to Cohen (1988). In addition, each ES was corrected
for sample size and adjusted to provide Hedges’ g (Lipsey and
Wilson, 2001). Finally, parameters were grouped to account for
different reporting metrics when e.g., coefficient of variation
vs. standard deviation of the same parameter was reported. In
order to assess the effect of different gait parameter groups in
PwPD, a mean ES for each gait parameter group was calculated
(ES′), with studies weighted according to their standard error
of measure. Heterogeneity was then assessed using Cochrane’s Q
and I2 statistics.
A binary logistic regression (BLR) analysis was then
performed on the most commonly reported gait parameter in
order to assess how this parameter discriminates the two groups
(i.e., HCs and PwPD). The logistic curve-fit was firstly analyzed
using the Chi-square goodness-of-fit test, while the quality
of the classification was evaluated using a receiver-operating
characteristic (ROC) procedure. We then identified the optimal
operating point, yoop with balanced levels of sensitivity as well
as specificity. yoop was then used in an inverse binary logistic
regression function in order to assess the optimal threshold value
xoop for the most commonly reported gait measures (Equation 1):
loge
(
yoop
1−yoop
− b0
)
b1
= xoop (1)
RESULTS
The 34 publications addressing walking performance in PwPD
included a total of 800 PwPD (mean age: 65.6 ± 12.2 years) and
854HCs (mean age: 65.5± 13.2 years). Clinically, disease severity
was most commonly evaluated using the Unified Parkinson’s
Disease Rating Scale (UPDRS part III) (17 studies; range of study
means: 6.2 to 50.2), followed by the Hoehn and Yahr scale (9
studies; range of study means: 1.6 to 2.8). Seven studies tested
patients in the off-medication condition, one study tested both
“on” and “off,” and the remaining studies measured in the on-
medication state (electronic Supplementary Table 1). All studies
measured subjects during overground walking for the evaluation
of gait, most commonly using footswitches (11 studies) followed
by pressure sensitive mats (8 studies), but also by using optical
motion capture systems (7 studies). Within the 34 publications,
some studies reported multiple gait parameters, resulting in a
total of 63 reported ES-values, with an overall I2-value of 42.3%
and Cochrane’s Q of 43.6. There were no significant differences
between off-medication and on-medication trials (ES′ = 0.71 vs.
ES′ = 0.75; p = 0.94). Eight parameter groups were identified,
with variability of stride time (SrT; 21 studies), variability of
stride length (SrL; 11 studies) and variability of step length (StL;
10 studies) being the most frequent. The majority of parameter
groups showed a positive ES′ (ranging from SrL= 0.36± 0.19 to
variability of double-limb support time= 1.30± 0.51), indicating
a general increase in gait variability in PwPD compared to HCs
(Figure 1). Only the parameter groups of step width variability
(StW) (3 studies; ES = −0.54 ± 0.38) and stance time variability
(SaT) (2 studies; ES = −0.24 ± 0.54) revealed a negative ES′,
indicative of lower levels of variability in PwPD as compared to
HCs.
The BLR was conducted on the parameter SrT, including a
total of 21 studies with 519 PwPD and 574 HCs, and revealed
an area under the ROC curve of 0.74, with a sensitivity of
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FIGURE 1 | Forest plot that presents the effect sizes for different gait parameter groups (see Table 1), where a positive ES represents increased
variability of PwPD compared to the HCs.
TABLE 1 | Effect size statistics including the z-test and p-values across all parameter groups.
Swing time Stride time Stride length Step width Step time Step length Stance time Double-limb support time
Mean effect size 0.75 0.63 0.36 −0.54 0.70 0.56 −0.24 1.30
Mean standard error 0.21 0.13 0.19 0.38 0.31 0.23 0.54 0.51
Comparisons 8 21 11 3 5 10 2 3
Z-test 3.48 4.99 1.94 −1.40 2.23 2.43 −0.44 2.66
p-value <0.1 <0.1 <0.1 0.16 <0.1 <0.1 0.66 <0.1
An alpha level of 10% was used to indicate significant differences in this meta-analysis (Higgins, 2011).
0.67 and a specificity of 0.78. In the inverse logistic regression,
the corresponding xoop value revealed an optimal coefficient of
variation of SrT of 2.4% [95%CI; 1.9 to 3.9] to discriminate
Parkinsonian gait from asymptomatic walking.
DISCUSSION
Measures of variability have become a popular target for the
assessment of gait function in PwPD. However, until now
normative values for physiological variability have been missing
and it remains unclear how specific gait parameters and their
combinations reflect a healthy walking pattern. This systematic
review and meta-analysis now provide evidence that 2.4% stride
time variability discriminates healthy from pathological walking.
More importantly, however, this analysis of the literature has,
for the first time, considered how different gait parameters are
indicative of pathological disturbances of the HSMS in PwPD.
Here, contrary to the common observation of increased levels
of variability during gait in these patients, the parameter of step
width variability is decreased, hence indicating less flexible motor
performance.
The majority of gait parameter groups showed positive ES
between PwPD and asymptomatic elderly subjects. This indicates
elevated levels of variability during walking in PwPD, which has
been associated with reduced walking stability (Dingwell and
Kang, 2007; Toebes et al., 2012) as well as a risk factor for
falling (Hausdorff et al., 1997; Hamacher et al., 2011; Kobayashi
et al., 2014; Konig et al., 2014a), which is a common problem
in advanced PwPD cohorts (Wood et al., 2002; Schaafsma et al.,
2003; Allen et al., 2011). Here, the parameter of stride time
variability in particular has shown to be sensitive in the prediction
of falls (Hamacher et al., 2011; Konig et al., 2014a), possibly since
variability of temporal gait measures (e.g., stride and step time)
depicts the concept of walking rhythmicity, where increased
temporal variability is typically associated with observations of
unsteady gait (Frenkel-Toledo et al., 2005; Lord et al., 2013).
From a neurophysiological perspective, one of the functions of
the basal ganglia, in particular the posterior putamen, substantia
nigra and globus pallidus, is to maintain rhythmicity during
repetitive motor tasks (Plotnik and Hausdorff, 2008; Takakusaki
et al., 2008; Lord et al., 2011b;Wu et al., 2015), which is supported
by the fact that intervention to these structures in the form of
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either dopamine replacement therapy or deep brain stimulation
has been shown to reverse degenerative changes to temporal
variability (Schaafsma et al., 2003; Hausdorff et al., 2009; Bryant
et al., 2016). It therefore seems entirely plausible that malfunction
or degeneration of specific basal ganglia structures might directly
contribute to increased temporal variability during gait in PwPD.
Unexpectedly, two parameter groups showed average negative
effect sizes, which is representative of reduced variability during
walking in PwPD. While variability of stance time exhibited
negative ES′, this parameter was only represented by two
extremely inconsistent studies and therefore clearly requires
further investigation before meaningful conclusions can be
drawn. For the parameter of step width variability, however, three
studies revealed a highly consistent ES′ of −0.54. This indicates
that the performance of the patients was less variable, or in other
words more rigid, than HCs. Step width variability has been
associated with balance performance during walking (Gabell and
Nayak, 1984). It is well-established that in PwPD, static as well
as dynamic balance is commonly disturbed (Allen et al., 2011;
Park et al., 2015; Rinalduzzi et al., 2015) but also that dopamine
replacement therapy usually lacks efficacy for reversing the effect
(Rocchi et al., 2002; Benatru et al., 2008; Curtze et al., 2015),
suggesting that neurophysiological structures other than dopa-
sensitive cortico-basal circuits (Takakusaki et al., 2008) (i.e., basal
ganglia) are involved in the control of balance during gait (Curtze
et al., 2015; Mancini et al., 2015). Here, the pedunculopontine
nucleus (PPN) has recently received considerable attention as a
major protagonist involved in the control of balance (Hamani
et al., 2007; Stefani et al., 2007; Takakusaki et al., 2008; Jahn and
Dieterich, 2011; Mancini et al., 2015; Wu et al., 2015). Thus,
we hypothesize that the observation of the opposite effect in
step width variability in PwPD (i.e., reduced) as compared to
parameters of temporal variability, could be explained by the
selective effects of pathology on different neurological structures.
From a human movement perspective, however, the
observed reduction in step width (spatial) variability, together
with an increase in all temporal parameters of variability,
might alternatively be explained by a motor compensation
mechanism. Here, rather than the direct degeneration of
specific neurophysiological structures that exclusively govern
particular gait parameters, the loss of control over walking
rhythmicity might be actively counter-balanced by tighter
regulation of spatial parameters of movement, specifically
step width. Here, it should be noted that the greatest effect
sizes were observed in the parameter group of double-limb
support time (DLS), which is a temporal parameter—therefore
affected by disturbances to gait rhythmicity—but one that is
also strongly associated with dynamic balance during walking
(Lord et al., 2011b). It is therefore conceivable that patients with
increased temporal variability compensate by regulating their
step width. Such alternative control mechanisms would suggest
that balance maintenance is a complex motor function that
requires control of both spatial (e.g., step width) and temporal
(e.g., DLS and stride time) domains (Todorov and Jordan,
2002), and therefore probably also requires the involvement
of different neurophysiological structures. However, further
investigation is clearly required to improve our understanding of
the relationships between different gait characteristics and their
interaction, as well as specific pathophysiology in PwPD.
There are certain limitations to this systematic review
of the literature that must be considered when interpreting
the presented results. Firstly, the reliability consistency of
testing protocols applied in the studies should be considered.
Specifically, it has been argued that at least 50 steps are required
to ensure reliable measures for walking variability (Konig et al.,
2014b), which was only fulfilled in 13 of the 34 (38%) studies.
However, testing protocols within a study were similar for both
the PwPD and HC groups, and therefore the approaches used
possessed equal levels of reliability. Previously, it was shown that
low reliability is caused by random error effects and its influence
on the derived effect size is therefore negligible (Konig et al.,
2014b). However, it is strongly suggested that walking protocols
include the assessment of more than 50 steps in future studies.
Secondly, a common limitation of reviews is their dependency
on publication bias. It seems plausible that results contradicting
common expectation on the relationship between pathological
and healthy walking performance (i.e., PwPD should exhibit
increased variability) are less likely to be published. This results
in a relatively higher number of studies presenting positive ESs,
which will overestimate the generalized effect of Parkinson’s
disease on walking performance. For the presented meta-analysis
of the literature, such bias could have affected our estimation of
the threshold level for stride time variability.
In conclusion, this systematic review and meta-analysis of
the literature provides the highest level of evidence for a
threshold of 2.4% CV of stride time to discriminate healthy
from Parkinsonian gait. Furthermore, it has been shown, that
not all gait parameters are equally increased in PwPD. In
particular, a decrease in step width variability might be indicative
of selective damage to specific neurophysiological structures
or alternatively an important compensation mechanism for
maintenance of gait stability. Although, the aetiology of disturbed
gait characteristics remains to be elucidated, this systematic
review is the most comprehensive study to examine the complex
interplay between spatial and temporal control in gait in PwPD.
However, an accurate analysis of neurophysiological damage in
PwPD, together with a reliable and comprehensive assessment
walking parameters could lay the foundations for improving our
understanding of disturbed walking and control mechanisms
during walking in man.
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